{{Rsnum
|rsid=12666575
|Gene=MAD1L1
|Chromosome=7
|position=1964786
|Orientation=plus
|GMAF=0.3264
|Gene_s=MAD1L1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 44.2 | 46.0 | 9.7
| HCB | 26.5 | 55.1 | 18.4
| JPT | 37.2 | 51.3 | 11.5
| YRI | 98.6 | 1.4 | 0.0
| ASW | 86.0 | 14.0 | 0.0
| CHB | 26.5 | 55.1 | 18.4
| CHD | 19.4 | 59.3 | 21.3
| GIH | 46.5 | 43.6 | 9.9
| LWK | 97.3 | 2.7 | 0.0
| MEX | 20.7 | 58.6 | 20.7
| MKK | 89.0 | 11.0 | 0.0
| TSI | 35.3 | 45.1 | 19.6
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22688191
|Trait=None
|Title=Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder.
|RiskAllele=
|Pval=2E-9
|OR=1.1200
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}